What is it about?
In this study, we find that administering a GluK5 antagonist within 20 minutes of a nerve agent exposure will prevent long term deficits in synaptic plasticity, and will prevent the associated increases in anxiety-like behavior.
Featured Image
Why is it important?
This work is important because it provides a novel treatment option to prevent long term deficits after a nerve agent exposure.
Read the Original
This page is a summary of: LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety, Neuropharmacology, February 2015, Elsevier,
DOI: 10.1016/j.neuropharm.2014.08.014.
You can read the full text:
Contributors
The following have contributed to this page